Last reviewed · How we verify
OXYBUTYNIN CHLORIDE
At a glance
| Generic name | OXYBUTYNIN CHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1975 |
Approved indications
Common side effects
- Dry mouth
- Dizziness
- Somnolence
- Constipation
- Nausea
- Blurred vision
- Urinary Hesitation
- Headache
- Nervousness
- Urinary tract infection
- Dyspepsia
- Urinary Retention
Serious adverse events
- Anaphylactic reactions requiring hospitalization
- Angioedema with airway obstruction
- QT interval prolongation
- Glaucoma
- Convulsions
- Psychotic disorder
- Hallucination
- Tachycardia
- Chest discomfort
- Urticaria
Key clinical trials
- Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial (NA)
- A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
- Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. (PHASE4)
- Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder. (PHASE2)
- Oxybutynin for Post-surgical Bladder Pain and Urgency (PHASE3)
- Behavioral Interventions Versus Pelvic Floor Muscle Therapy as Adjuncts to Anticholinergic Pharmacotherapy for Urgency Urinary Incontinence: A Non-Inferiority Trial (NA)
- Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population (NA)
- A Novel Pharmacological Therapy for Obstructive Sleep Apnea (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OXYBUTYNIN CHLORIDE CI brief — competitive landscape report
- OXYBUTYNIN CHLORIDE updates RSS · CI watch RSS